Error: Could not add to watchlist. X
+ Watchlist

Opthea Ltd

CKDXY:US
OTC US
USD
Volume
0
Previous Close
8.00
52Wk Range
2.21 - 8.00
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Previous Close
8.00
52Wk Range
2.21 - 8.00
Current P/E Ratio (TTM)
-
Earnings per Share (AUD) (TTM)
-
Market Cap (m USD)
115.270
Shares Outstanding (m)
40.098
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.53%
% Price Change
+0.52%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Opthea Limited is a biologics drug developer for ophthalmic diseases. The Company develops therapies for diabetic macular edema, corneal neovascularization and transplantation, and dry eye disease. Opthea serves patients and healthcare providers in Australia.
Address
Suite 0403, Level 4
650 Chapel Street
South Yarra, VIC 3141
Australia
Phone
61-3-9826-0399
  • Megan Baldwin
    Managing Director/CEO
  • Michael Tonroe "Mike"
    CFO/Secretary
  • Ian Leitch
    Director:Clinical Research
  • Michael Gerometta "Mike"
    Head:CMC Development
  • Richard Chadwick
    Head:Intellectual Property
Show More